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Abstract 
A method combining field asymmetric waveform ion mobility spectrometry with liquid 
chromatography-mass spectrometry (LC-FAIMS-MS) has been developed for the analysis of the 
oxypurine compounds hypoxanthine (HX) and xanthine (XA) in saliva. Separation of the oxypurines 
from interfering matrix components was investigated using FAIMS-MS. The selected FAIMS 
parameters were then applied to the rapid LC-FAIMS-MS analysis of HX and XA using a short 
chromatographic separation method (7 min). A comparison of the LC-MS method with and without 
FAIMS applied, resulted in improved discrimination from saliva matrix interferences and improved 
chromatographic peak integration for both HX and XA using a FAIMS separation. A quantitative 
evaluation of the LC-FAIMS-MS method was performed giving limits of detection of 2.0 ng mL-1 for 
HX and 1.8 ng mL-1 for XA, and limits of quantification of 6.6 ng mL-1 for HX and 6.0 ng mL-1 for 
XA. The developed LC-FAIMS-MS method was applied to the targeted analysis of the oxypurine 
metabolites in saliva collected from healthy male athletes (n=11) before and after exercise designed to 
induce oxidative stress; post-exercise collection time-points included immediately after exercise, one 
hour and twenty-four hours’ post-exercise. The salivary concentrations of both HX and XA were 
lower after physical exercise, compared to the pre-exercise (rest) concentrations and returned to 
approximately pre-exercise levels after twenty-four hours. The method reported has the potential for 
monitoring the salivary oxypurines, HX and XA, as biomarkers of oxidative stress and in other 
clinical applications.  
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Introduction 
Exhaustive exercise and overtraining can have major health implications for athletes, and exercise 
induced oxidative stress and inflammation can be associated with many known diseases (Halliwell et 
al. 1993; Vollaard et al. 2005). The identification of biomarkers of oxidative stress could therefore 
lead to the early identification and effective treatment of diseases and chronic inflammation 
(Margonis et al. 2007). Exercise induced muscle fatigue or muscular stress has previously been 
related to oxidative stress, ATP depletion, muscle damage or immunological compromise (Speranza 
et al. 2007; Al-Shehri 2015; Li 2015; Finsterer et al. 2016; Chan 2018).  
The oxypurine compounds hypoxanthine (HX) and xanthine (XA) are naturally occurring purine 
derivatives (Figure 1), which are derived from the degradation of purine nucleotides (adenine and 
guanine). They have been positively correlated with ATP consumption and the formation of free 
radicals and reactive oxygen species (Finsterer 2012; Radak et al. 2008). HX is also produced by the 
action of xanthine oxidase on XA, or from the reduction of XA by xanthine oxidoreductase (XOR). In 
the purine catabolism, XOR catalyses the oxidative hydroxylation of HX to XA and subsequently of 
XA to uric acid (UA). UA acts as a potent antioxidant and free radical scavenger associated with 
oxidative stress and other diseases (Guan et al. 2004, 2005; Yigla et al. 2007). XOR therefore has 
important functions as a cellular defence enzyme against oxidative stress (Valko et al. 2007). HX and 
XA are usually analysed in plasma, serum or urine, and it has been reported that plasma and or 
urinary levels of these oxypurines can changes as a result of oxidative stress (Catinella et al. 2001; 
Murray 1966). In a study of twenty healthy males performing exercise to exhaustion, serum HX and 
XA levels were found to significantly increase post exercise, leading to the proposal of oxypurines as 
biomarkers of oxidative stress and muscle fatigue (Speranza et al. 2007). Similar results were also 
observed in the analysis of HX and XA in plasma where an increase in concentrations of both HX and 
XA were observed post-exercise, with a peak increase in the levels of HX post exercise of nearly nine 
times the resting level (Hellsten-Westing et al. 1994). HX has been suggested as an indicator of the 
effectiveness of a training regime (Zielinski et al. 2011), and as a potential biomarker to normalise for 
metabolomic changes due to exercise, although further research is required (Daskalaki et al. 2015, 
2014). 
HX and XA have been detected in plasma, serum or urine using a variety of methods including high 
performance liquid chromatography (HPLC) and capillary electrophoresis (Guan et al. 2004, 2005; 
Markelj et al. 2016). These oxypurines have also been detected in saliva (Al-Shehri et al. 2013; Guan 
et al. 2004, 2005; Kochanska et al. 2000; Markelj et al. 2016), which is known to change in response 
to a variety of different physiological states (Dame et al. 2015). However, saliva is a complex biofluid 
which can require careful sample preparation and/or extended analysis times to separate HX and XA 
from co-eluting matrix interferences. This results in the relatively long analysis times (15-60 min) 
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reported for the liquid chromatography-mass spectrometry (LC-MS) analysis of HX, XA and 
structurally related purine compounds in saliva and other biofluids (Al-Shehri et al. 2013; Flanders et 
al. 2005; Ito et al. 2000; Lu et al. 2006; Ong et al. 2010).  
The performance of liquid chromatographic separation can be improved by the use of ultra-high 
performance liquid chromatography (UHPLC) and high resolution mass spectrometry (HRMS), using 
time-of-flight (TOF) or Orbitrap mass analysers, or by tandem MS. However, even the highest 
resolution mass analysers cannot separate isobaric analytes and matrix interferences. An alternative 
approach to enhancing the selectivity and performance of LC-MS analyses is the incorporation of a 
rapid gas-phase ion separation technique such as ion mobility spectrometry (IMS) in combination 
with LC-MS using either drift tube IMS or field asymmetric waveform ion mobility spectrometry 
(FAIMS), also known as differential ion mobility spectrometry. FAIMS separates ions based on 
differences in the mobility of ions in low and high electric fields, which is a separation mechanism 
that is highly orthogonal to LC and MS. The combination of a miniaturised FAIMS device with LC-
MS has been shown to improve selectivity and limits of detection and quantification without loss of 
linear dynamic range, whilst reducing interfering chemical noise in the analysis of complex biofluids 
(Arthur et al. 2017; Brown et al. 2012; Smith et al. 2013). Here, we report the development of a rapid 
LC-FAIMS-MS method, requiring minimal sample pre-treatment, for the determination of the 
oxypurines HX and XA in saliva. The method has been applied to the analysis of saliva samples 
collected from male cyclists pre- and post-exhaustive exercise.  
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Experimental  
Chemicals 
HPLC grade acetonitrile (ACN) and HPLC grade water (H2O) were both purchased from Fisher 
Scientific (Loughborough, UK). HX, XA, 1-methylxanthine-(methyl-13C,d3) (1-MXd3) and formic acid 
(FA) were all purchased from Sigma Aldrich (Dorset, UK). Individual standard solutions of HX (1 µg 
mL-1), XA (1 µg mL-1) and 1-MXd3 (0.5 µg mL-1) were prepared in H2O:ACN v/v 95:5 with 0.1% FA 
for FAIMS-MS analysis. A solution of 1-MXd3 (0.3 µg mL-1) was prepared in H2O:ACN v/v 92.5:7.5 
with 0.15% FA for spiking into saliva for LC-FAIMS-MS analysis of saliva samples. Calibration 
standard solutions of HX and XA were prepared in H2O:ACN v/v 92.5:7.5 with 0.15% FA for spiking 
into a pooled saliva extract during sample preparation to give final concentrations (post-spiking) of 
HX and XA of 20, 40, 60, 80 and 100 ng mL-1, and 200 ng mL-1 of 1-MXd3, along with an extract 
spiked only with 1-MXd3.  
Saliva sample collection 
Saliva samples were collected from trained male cyclists (n=11) aged between 18-45. Prior to the 
exercise performance test, participants were asked to arrive in a euhydrated and fasted state (from 10 
pm the day prior to the test) and to refrain from caffeinated and alcoholic beverages for twenty-four 
hours prior to the test. Ethical approval for the study was obtained from the local ethical advisory 
committee (Ethical Advisory Committee, Loughborough University) with reference numbers: R14-
P72, G10-P24 and G10-P23. Saliva was collected from participants pre-exercise, immediately post-
exercise, one-hour post-exercise and twenty-four hours post exercise. The exhaustive exercise 
consisted of cycling on a cycle ergometer sub maximally at 70% of their maximum power output 
(determined via a pre-testing session to measure maximum power output) for 45 minutes and then to 
cycle the greatest distance possible for a further 15 minutes. The one hour cycling exercise protocol 
was designed to induce oxidative stress (Wilson et. al. 2017).  
Saliva was collected by a passive drool method where participants were asked to sit comfortably with 
their head tilted forward, to allow saliva to pool in the front of the mouth (Chiappin et al. 2007; 
Malkar et al. 2013). Saliva was dribbled from the mouth into a glass collection vial (30 mL, 
Chromacol, UK) at regular intervals. This process was continued for at least 5-10 minutes to provide 
1.5 – 2 mL of saliva. Saliva collected from all participants was re-aliquoted into 600 µL aliquots into 
microcentrifuge tubes (2 mL LoBind Eppendorf, Sigma Aldrich, UK). 600 µL from all participants 
was pooled together and re-aliquoted as 600 µL aliquots to be used for method development and 
quality control (QC). Samples were aliquoted over ice prior to storage to minimise freeze-thaw cycles 
and stored at -80°C to arrest biological activity.  
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Saliva sample pre-treatment 
Saliva samples stored at -80°C were thawed at room temperature for 20 min. Each sample was 
vortexed for 30 s followed by centrifugation at 10,000 g for 10 min at ambient temperature. An 
aliquot of the supernatant (250 µL) was transferred to a fresh microcentrifuge tube and diluted with 
500 µL of an internal standard solution (1-MXd3 (0.3 µg mL-1) in H2O:ACN v/v 92.5:7.5 with 0.15% 
FA) to prepare the sample at the starting mobile phase conditions (H2O:ACN v/v 95:5 with 0.1% FA), 
giving a final internal standard concentration of 0.2 µg mL-1. The diluted supernatant was vortexed for 
30 s to ensure homogeneity and transferred to an autosampler vial (2 mL) for LC-FAIMS-MS 
analysis.  
Instrumentation 
Analysis was performed using an Agilent 1200 series HPLC interfaced to an Agilent 6230 TOF mass 
spectrometer fitted with a modified Jet Stream electrospray ionisation (ESI) source (Agilent 
Technologies, Santa Clara, USA) to accommodate the FAIMS. The miniaturised chip-based 
ultraFAIMS device (Owlstone Medical Ltd), described in detail elsewhere (Brown et al. 2010), was 
located in front of the transfer capillary of the MS behind a modified spray shield within the ESI 
source. The electrodes of the FAIMS chip are arranged as multiple parallel channels, with a trench 
length of 78.1 mm, a 100 µm electrode gap and a path length of 700 µm. Nitrogen (N2) was used as 
the carrier gas for the FAIMS and the MS drying gas. Samples were introduced into the ESI source 
either by direct syringe infusion at a flow rate of 10 µL min-1 (for initial FAIMS optimisation by 
FAIMS-MS) or by the LC. Chromatographic separations were performed on an Agilent Poroshell 120 
EC-C18 reversed phase column of dimensions 2.1 x 75 mm, 2.7 µm (Agilent Technologies, Santa 
Clara, USA), with a 5 mm guard column of the same phase attached in series prior to the analytical 
column.  
HPLC conditions 
Mobile phase A consisted of 0.1% aqueous formic acid (v/v) and mobile phase B was 0.1% formic 
acid in ACN. The mobile phase flow rate was set to 0.3 mL min-1 and the column was maintained at 
40°C. Saliva samples were analysed with an injection volume of 10 µL by the chromatographic 
gradient programme: 5% B (0 min), increased to 8% B (0-2 min) for the retention of the oxypurine 
compounds, followed by a column clean-up and equilibration phase by increasing from 8% B to 95% 
B (2-3 min), hold (3-4 min), then returning to initial conditions of 5% B (4-5 min) and hold (5-7 min).   
MS Conditions 
The TOF-MS was operated in positive ion mode with a scan rate of 10 scans s-1 for FAIMS-MS 
analysis, and at 2 scans s-1 for LC-FAIMS-MS analysis. For all analyses the MS parameters were as 
follows: m/z range 50-1200, nebulizer pressure was set to 35 psig with a sheath gas (N2) flow of 11 L 
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min-1 at 350°C, with a nozzle voltage of 2000 V. The capillary voltage was set to 4000 V, the 
fragmentor voltage was set to 150 V and the drying gas (N2) flow set to 10 L min-1 at 150°C. 
Optimisation of FAIMS conditions 
FAIMS-MS analyses of HX and XA were performed using a two-dimensional FAIMS scan (or 
sweep) in the dispersion field (DF) range from 180-300 Td, in steps of 10 Td, and compensation field 
(CF) range from -2-5 Td, in steps of 0.05 Td (where 1 Td = 10-17 V cm2). The DF and CF selected for 
the LC-FAIMS-MS analysis of saliva were optimised as DF 230 Td and CF 0.90 Td with the TOF-
MS operated in positive ion mode. 
Analytical protocol for LC-FAIMS-MS salivary analysis 
The sample list for analysis was randomised using Microsoft Excel. A series of five consecutive 
injections of a pooled saliva extract were run prior to sample analysis to condition the 
chromatographic column. A pooled saliva extract was analysed after every five saliva samples as a 
QC sample. Method blanks demonstrated no carry-over between saliva sample runs.  
Data Processing 
Data were acquired using the FAIMS Control software in combination with the MassHunter 
Acquisition software. MassHunter Qualitative Analysis software version B.05.00 (Agilent 
Technologies, Santa Clara, USA) was used for processing raw LC-MS and LC-FAIMS-MS data. A 
modified prototype version of the MassHunter Qualitative Analysis software was used for processing 
raw FAIMS-MS data, with a mass extraction window of m/z ± 0.02. Microsoft Excel and PowerPoint 
2010 (Microsoft, Seattle, USA), and OriginLab 2015 (Academic version, b9.2.272) were used to 
produce figures in this report.  
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Results and Discussion 
LC-FAIMS-MS method development for the analysis of HX and XA 
A short chromatographic method (7 min) was developed for HX, XA and the internal standard 1-
MXd3 with the analytes eluting in < 2 min and the remainder of the chromatographic method used to 
wash-out the saliva matrix and re-equilibrate the column. The retention times for the extracted ion 
chromatograms (EICs) of the [M+H]+ ions for HX (m/z 137.0458, 100 ng mL-1), XA (m/z 153.0407, 
100 ng mL-1) and 1-MXd3 (m/z 171.0791, 200 ng mL-1) are 0.88 min (Figure 2 (a)), 0.95 min (Figure 2 
(b)) and 1.62 min respectively. In the EICs for m/z 137.0458 and m/z 153.0407 from an unspiked 
pooled saliva extract (Figure 2 (c) and (d)), co-eluting matrix interferences are observed, with HX 
(Figure 2 (c)) unresolved from these interferences and XA is not baseline resolved (Figure 2 (d)).  
Selection of optimal FAIMS conditions for the targeted analysis of HX and XA in saliva by LC-
FAIMS-MS was determined by the removal of co-eluting matrix interferences to improve the signal-
to-noise ratio (S:N), peak area, peak height and peak shape compared to LC-MS alone. The oxypurine 
compounds and the internal standard (1-MXd3) were first analysed as individual standard solutions 
along with an unspiked pooled saliva extract (post sample preparation). The samples were directly 
infused into the ESI source and analysed by FAIMS-MS, in order to select FAIMS DF and CF 
parameters to be further tested using LC-FAIMS-MS. FAIMS-MS analysis was performed by 
scanning the DF from 180 to 300 Td in 10 Td steps and the CF from -2 to 5 Td in 0.05 Td steps. 
Figure 3 (a) shows that ions from the saliva extract are observed in the CF range from -2 to 3 Td at 
DF 230 Td, with the highest intensity at 2 Td. The selected CF responses for HX and XA in Figure 3 
(a) are in the CF range 0 to 1.5 Td overlapping the CF total ion chromatogram (TIC) which shows the 
entire ion response obtained from the saliva extract. Three DF/CF conditions were selected where HX 
and XA are transmitted by the FAIMS along with the internal standard 1-MXd3: CF 0.7 Td at DF 220 
Td (Figure 3 (b)), CF 0.9 Td at DF 230 Td (Figure 3 (c)), and CF 1.1 Td at DF 240 Td (Figure 3 (d)).  
The three FAIMS conditions selected were applied to the LC-FAIMS-MS analysis of an unspiked 
saliva extract in order to determine the optimum DF/CF combination for the transmission of HX, XA 
and 1-MXd3. EICs for HX (m/z 137.0458 ± 0.02, 0.91 min) and XA (m/z 153.0407 ± 0.02, 0.96 min) 
are shown in Figure 4. Each of the three FAIMS conditions resulted in a reduction of the co-eluting 
interferences in the EICs for HX (Figure 4 (b) to (d)) and XA (Figure 4 (f) to (h)) compared to LC-
MS (Figure 4 (a) and (e)). The S:N ratio of both HX and XA was increased in comparison to LC-MS 
for all three FAIMS conditions by an average of 230% for HX and 255% for XA. CF 1.1 Td at DF 
240 Td resulted in the largest reduction of co-eluting matrix interferences, but also had the largest 
reduction in the peak intensity at the highest DF. CF 0.7 Td at DF 220 Td had the highest peak 
intensity, but the least reduction in the co-eluting matrix interferences. CF 0.9 Td at DF 230 Td was 
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therefore selected as the FAIMS condition for the analysis as a compromise between peak intensity 
and separation of co-eluting matrix interferences.  
The LC-MS chromatographic method was developed to minimise the run time for HX and XA, but 
this resulted in a significant overlap of the HX peak with salivary matrix components. The observed 
co-elution of HX with matrix components could be reduced by changing the chromatographic 
gradient to separate the metabolite from the saliva matrix, at the cost of increased chromatographic 
run time. Options to improve the selectivity of HX without increasing chromatographic run time 
include the selection of a narrower mass extraction window using HRMS or the application of FAIMS 
separation combined with LC-MS (Smith et al. 2013). A direct comparison of both techniques to 
improve selectivity for HX without increasing the run time is shown in Figure 5. The LC-MS and LC-
FAIMS-MS EICs for the [HX+H]+ ion (m/z 137.0458) for the analysis of HX in an unspiked pooled 
saliva sample, with a high resolution mass window of m/z 137.0458 ± 0.02 is shown in Figure 5 (a). 
The absolute intensity of the HX peak, with FAIMS switched off, is reduced by a factor of two if the 
mass extraction window is narrowed from ± 0.02 (Figure 5 (a)) to m/z 137.0458 ± 0.008 (Figure 5 
(b)), but there is no further discrimination against the co-eluting saliva matrix interference. In contrast, 
the application of FAIMS separation shows a significant reduction in the co-eluting chemical noise 
from the saliva matrix (Figure 5 (c) and (d)) whilst maintaining the rapid elution time. The removal of 
chemical noise from the saliva matrix resulted in improved peak integration and S:N even though the 
absolute intensity of the HX peak was reduced due to ion losses in the FAIMS device. Comparison of 
the two mass extraction windows with FAIMS on, m/z 137.0458 ± 0.02 (Figure 5 (c)) and m/z 
137.0458 ± 0.008 (Figure 5 (d)), resulted in a reduction of sensitivity without a significant increase in 
S:N. Therefore, the ± 0.02 mass extraction window was selected for subsequent LC-FAIMS-MS 
analyses. The mass spectrum from the HX peak with the FAIMS off showed HX with a mass error of 
-9.6 ppm (m/z 137.0471). Whereas with FAIMS applied (LC-FAIMS-MS) the observed mass error 
was -0.82 ppm (m/z 137.0459), as a result of discrimination against isobaric co-eluting saliva matrix 
interferences.  
Table 1 compares the quantitative performance of the LC-MS and LC-FAIMS-MS methods for the 
determination of HX and XA using standard additions spiked into a pooled saliva sample. From Table 
1, the limit of detection (LOD; S:N 3:1)) for HX was reduced from 3.8 ng mL-1 (FAIMS off) to 2.0 ng 
mL-1 (FAIMS on), and the limit of quantification (LOQ; S:N 10:1) was also reduced from 12.6 ng 
mL-1 (FAIMS off) to 6.6 ng mL-1 (FAIMS on), based on the extracted ion peak areas of HX (m/z 
137.0458 ± 0.02) using LC-FAIMS-MS. The LOD and LOQ for XA were similar at 1.9 ng mL-1 and 
6.2 ng mL-1 (FAIMS off) and 1.8 ng mL-1 and 6.0 ng mL-1 (FAIMS on), based on the extracted ion 
peak areas of XA (m/z 153.0407 ± 0.02) using LC-FAIMS-MS. The intra-day reproducibility of the 
LC-FAIMS-MS system was compared with LC-MS by analysing HX and XA spiked into saliva (100 
ng mL-1, Table 1) in both FAIMS on and FAIMS off modes. Relative standard deviations (%) 
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sufficient for good quantitation were obtained with both LC-MS and LC-FAIMS-MS (1.7% - 6.6%). 
These data for HX demonstrate the FAIMS device can enhance quantitative performance compared to 
high resolution LC- MS.  
LC-FAIMS-MS determination of salivary hypoxanthine and xanthine pre- and post-
oxidative stress 
The LC-FAIMS-MS method developed for the analysis of HX and XA was applied to the analysis of 
saliva samples collected from cyclists pre-exercise, immediately post-exercise, one-hour post exercise 
and twenty-four hours post exercise. A large biological variance between participants was observed in 
the pre-exercise saliva samples with concentrations in the range 3.1 - 242.9 ng mL-1 (0.02 – 1.8 uM) 
for HX and 22.4 to 1183.1 ng mL-1 (0.15 – 7.8 uM) for XA (Supplementary Table 1 and 
Supplementary Table 2). These XA and HX concentrations are within the ranges previously reported 
in saliva, although at the lower end of the range for HX (Kochanska et al. 2000; Al-Shehri 2013; Al-
Shehri 2015). Figure 6 shows box and whisker plots of HX and XA concentrations for male 
participants pre- and post-exercise. Despite the biological variance in the salivary HX and XA levels 
pre-exercise, the same overall trend towards lower concentrations immediately after exercise and for 
the next hour post-exercise is observed, with the levels of HX and XA returning to approximately pre-
exercise levels in the twenty-four hours post-exercise samples. The observation of lower HX and XA 
levels in saliva after the physical exercise (Figure 6) is the opposite of the trend previously reported 
for plasma concentrations of HX, which increased immediately post-exhaustive physical exercise 
(Hellsten-Westing et al. 1994; Speranza et al. 2007). Lower levels of HX and XA (Figure 6) may be 
due to changes in enzymatic activity in saliva after exercise (Ligtenberg et al. 2015; Walsh 1999).  
However, significant inter-day variations in salivary levels of HX and XA (and UA) have been 
reported by Kochańska et al., which may explain the variations in HX and XA concentrations 
observed in this study. Markelj et al. (Kochanska et al. 2000; Markelj et al. 2016) reported the 
analysis of saliva and urine by LC-MS, which showed that concentrations of HX and XA were 
significantly lower, relative to the concentration of UA, in saliva than in urine, although salivary UA 
has been shown to have a linear correlation with serum UA concentrations (Soukup et al. 2012). 
Further work is required to understand the relative levels of HX, XA and UA in saliva as a result of 
oxidative stress.   
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Conclusion 
A rapid (7 min) method combining miniaturised FAIMS with LC-MS and non-invasive sampling has 
been developed for the determination of HX and XA in saliva. Using LC-FAIMS-MS, improved 
chromatographic peak integration was possible, in comparison to LC-MS, due to the reduction in the 
co-eluting chemical interferences from the saliva matrix. This also resulted in improved mass 
spectrometric observed mass error using HRMS, aiding in the qualitative identification and 
quantitation of the purine based derivatives, HX and XA. Saliva samples analysed from healthy male 
athletes showed a decrease in salivary oxypurines immediately post-exercise and one-hour post-
exercise, in comparison to levels determined pre-exercise and twenty-four hours’ post-exercise, which 
suggests that both HX and XA could be used as biomarkers of oxidative stress. The combination of 
LC-FAIMS-MS with the non-invasive sampling collection technique for saliva has potential as a rapid 
and high-throughput screening technique for  oxidative stress, based on the determination of 
oxypurine metabolite biomarkers, as well as in other clinical applications.  
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